Tag: Clinical Trail News
Sequana Medical’s IND application to begin the phase 1/2a MOJAVE study with DSR 2.0 to treat congestive heart failure has been approved by the US FDA.
The US Food and Drug Administration (FDA) has approved Sequana Medical NV’s investigational new drug (IND) application for…
New US FDA certifications for Abbott’s life support system will enable medical professionals to treat more seriously ill patients.
The US Food and Drug Administration (FDA) recently granted Abbott two more clearances for the company’s market-leading life…
Registration Form
This will close in 0 seconds
